The Success of Treatment Free Remission in Chronic Myeloid Leukaemia in Clinical Practice: A Single-Centre Retrospective Experience from South Africa

Figure 2

Kaplan–Meier estimates of TFR after TKI discontinuation in 12 patients with chronic myeloid leukaemia attempting TFR. The estimated survival without loss of major molecular response (failed TFR) at 12 months (media follow-up) was 75% for patients attempting TFR. TFR: treatment-free remission; TKI: tyrosine kinase inhibitor.